Caplacizumab for congenital thrombotic thrombocytopenic purpura

被引：6
|
作者：
Boothby, Aaron [1 ]
Mazepa, Marshall [1 ]
机构：
[1] Univ Minnesota, Sch Med, Dept Med, 420 Delaware St SE,MMC 480, Minneapolis, MN 55455 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 11期
关键词：
D O I：
10.1002/ajh.26693
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E420 / E421
页数：2
相关论文
共 50 条
  • [21] USE OF CAPLACIZUMAB IN PEDIATRIC THROMBOTIC THROMBOCYTOPENIC PURPURA PATIENTS
    Graciaa, Sara
    Sidonio, Robert
    Zerra, Patricia
    Rollins, Margo
    Briones, Michael
    Chonat, Satheesh
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S139 - S139
  • [22] Caplacizumab treatment for acquired refractory thrombotic thrombocytopenic purpura
    Khan, Sundas
    Landry, Kara
    Umyarova, Elvira
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (02) : E44 - E46
  • [23] Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab
    Cilla, Nicolas
    Dallemagne, Julie
    Vanhove, Marie
    Stordeur, Patrick
    Motte, Serge
    De Wilde, Virginie
    JOURNAL OF HEMATOLOGY, 2020, 9 (03) : 84 - 88
  • [24] Congenital thrombotic thrombocytopenic purpura
    von Krogh, Anne Sophie
    Waage, Anders
    Quist-Paulsen, Petter
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (17) : 1452 - 1457
  • [25] A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura
    Gomez-Segui, Ines
    Fernandez-Zarzoso, Miguel
    de la Rubia, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (11) : 1153 - 1164
  • [26] Thrombotic thrombocytopenic purpura in caplacizumab era-An individualized approach
    Sarode, Ravi
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (02)
  • [27] Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
    Elverdi, Tugrul
    Eskazan, Ahmet Emre
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1251 - 1258
  • [28] Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Hannah A. Blair
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 263 - 270
  • [29] Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)
    Estcourt, L. J.
    TRANSFUSION MEDICINE, 2019, 29 (03) : 146 - 148
  • [30] Caplacizumab Speeds Resolution of Acute Episodes of Thrombotic Thrombocytopenic Purpura
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 194 - 194
12345